Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

When the new coronavirus arrived in early 2020, people with asthma were identified as being at higher risk from the disease. Judgements about who was at increased risk had to be made on the best available evidence – which wasn’t much. Data from China was only just emerging and COVID-19 had yet to reach pandemic status.

Given that asthma is a lung disease and COVID-19 targets the lungs, it made sense that people with asthma would be considered at higher risk, as they are from other respiratory illnesses. But as more data emerged, the picture became less clear.

Read the full article on The Conversation website, written by Jamie Hartmann-Boyce (Nuffield Department of Primary Care Health Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.